title: Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study.
abstract: In patients with migraine with or without aura the prophylactic effect of amitriptyline (AMT) and venlafaxine (VLF) was compared in a randomized double-blind crossover study. Intolerable side effects resulted in drop out of five patients on AMT (due to hypersomnia, difficulty in concentration and orthostatic hypotension) and one patient on VLF (because of nausea and vomiting). Following the run-in period the patients (n = 52) were randomly treated with one of the study medications for 12 weeks. After a wash-out period lasting 4 weeks the patients were treated with the other drug for further 12 weeks. Both drugs had significant beneficial effect on pain parameters. Total number of side effects of VLF was low when compared with the side effect profile of AMT. In conclusion, it is suggested that VLF may be considered for the prophylaxis of migraine because of its low and/or tolerable side effect properties.
authors.affiliation: Department of Neurology, Faculty of Medicine, Firat University, TR 23119 Elazig, Turkey. serpilbulut@firat.edu.tr
authors.forename: Serpil
authors.initials: S
authors.lastname: Bulut
authors.forename: M Said
authors.initials: MS
authors.lastname: Berilgen
authors.forename: Aslihan
authors.initials: A
authors.lastname: Baran
authors.forename: Aslan
authors.initials: A
authors.lastname: Tekatas
authors.forename: Murad
authors.initials: M
authors.lastname: Atmaca
authors.forename: Bulent
authors.initials: B
authors.lastname: Mungen
mesh_terms: D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003511:Cyclohexanols / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000639:Amitriptyline; D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride